BR9712259A - Colostrininin, uso do mesmo, processos de tratar distúrbios do sistema nervoso central e/ou do sistema imune, de preparar colostrinin de colostro de mamìferos e de produzir uma composição farmacêutica, composição farmacêutica, suplemento dietético, nanopeptìdeo, e, uso do mesmo. - Google Patents

Colostrininin, uso do mesmo, processos de tratar distúrbios do sistema nervoso central e/ou do sistema imune, de preparar colostrinin de colostro de mamìferos e de produzir uma composição farmacêutica, composição farmacêutica, suplemento dietético, nanopeptìdeo, e, uso do mesmo.

Info

Publication number
BR9712259A
BR9712259A BR9712259-9A BR9712259A BR9712259A BR 9712259 A BR9712259 A BR 9712259A BR 9712259 A BR9712259 A BR 9712259A BR 9712259 A BR9712259 A BR 9712259A
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
colostrum
central nervous
processes
producing
Prior art date
Application number
BR9712259-9A
Other languages
English (en)
Portuguese (pt)
Inventor
Marin Janusz
Jozef Lisowski
Anna Dubowska-Inglot
Original Assignee
Hirszfeld Ludwick Pan Inst
Georgiades Biotech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hirszfeld Ludwick Pan Inst, Georgiades Biotech Ltd filed Critical Hirszfeld Ludwick Pan Inst
Publication of BR9712259A publication Critical patent/BR9712259A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Psychiatry (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Psychology (AREA)
BR9712259-9A 1996-10-03 1997-10-03 Colostrininin, uso do mesmo, processos de tratar distúrbios do sistema nervoso central e/ou do sistema imune, de preparar colostrinin de colostro de mamìferos e de produzir uma composição farmacêutica, composição farmacêutica, suplemento dietético, nanopeptìdeo, e, uso do mesmo. BR9712259A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL96316416A PL185442B1 (pl) 1996-10-03 1996-10-03 Środek farmaceutyczny o działaniu immunologicznym i psychotropowym, jego postać terapeutyczna oraz zastosowanie
PCT/GB1997/002721 WO1998014473A1 (en) 1996-10-03 1997-10-03 Colostrinin, and uses thereof

Publications (1)

Publication Number Publication Date
BR9712259A true BR9712259A (pt) 2000-01-25

Family

ID=20068412

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9712259-9A BR9712259A (pt) 1996-10-03 1997-10-03 Colostrininin, uso do mesmo, processos de tratar distúrbios do sistema nervoso central e/ou do sistema imune, de preparar colostrinin de colostro de mamìferos e de produzir uma composição farmacêutica, composição farmacêutica, suplemento dietético, nanopeptìdeo, e, uso do mesmo.

Country Status (18)

Country Link
US (2) US6852700B1 (enExample)
EP (1) EP0932623A1 (enExample)
JP (2) JP2001501929A (enExample)
KR (2) KR100508764B1 (enExample)
CN (2) CN1535722A (enExample)
AR (1) AR013612A1 (enExample)
AU (1) AU4565197A (enExample)
BR (1) BR9712259A (enExample)
CA (1) CA2266859C (enExample)
CZ (1) CZ298215B6 (enExample)
GB (1) GB2333453B (enExample)
HU (1) HUP9904368A3 (enExample)
IL (1) IL129211A (enExample)
PL (1) PL185442B1 (enExample)
RU (1) RU2217152C2 (enExample)
TR (1) TR199901022T2 (enExample)
WO (1) WO1998014473A1 (enExample)
ZA (1) ZA978885B (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL185442B1 (pl) 1996-10-03 2003-05-30 Georgiades Biotech Ltd Środek farmaceutyczny o działaniu immunologicznym i psychotropowym, jego postać terapeutyczna oraz zastosowanie
CN1322214A (zh) 1998-05-27 2001-11-14 吉马生物技术有限公司 用LAIT/sCD14－蛋白诱导抗生蛋白和抗生多肽
JP2002517454A (ja) * 1998-06-10 2002-06-18 アルバート ビー クラム 健康保護性腸管ミクロフローラの創造／維持及び免疫系の増強のための予防的及び治療的栄養サプリメント
GB9813031D0 (en) * 1998-06-16 1998-08-12 Regen Biotech Limited Dietary supplement
GB9912852D0 (en) * 1999-06-02 1999-08-04 Regen Therapeutics Plc Peptides
US7119064B2 (en) * 1999-08-17 2006-10-10 Board Of Regents, The University Of Texas System Use of colostrinin, constituent peptides thereof, and analogs thereof as modulators of intracellular signaling molecules
AU7061700A (en) 1999-08-17 2001-03-13 University Of Texas System, The Use of colostrinin, constituent peptides thereof, and analogs thereof as oxidative stress regulators
DE60036638T2 (de) * 1999-08-17 2008-02-21 The University Of Texas System, Austin Verwendung von colostrinin, dessen peptidbestandteile und deren analoga zur förderung der neuronalen zelldifferenzierung
US6852685B1 (en) * 1999-08-17 2005-02-08 Board Of Regents, The University Of Texas System Use of colostrinin, constituent peptides thereof, and analogs thereof to promote neuronal cell differentiation
WO2001011937A2 (en) * 1999-08-17 2001-02-22 The University Of Texas System Use of colostrinin, constituent peptides thereof, and analogs thereof for inducing cytokines
US6903068B1 (en) * 1999-08-17 2005-06-07 Board Of Regents, The University Of Texas System Use of colostrinin, constituent peptides thereof, and analogs thereof for inducing cytokines
GB0001825D0 (en) * 2000-01-26 2000-03-22 Regen Therapeutics Plc Peptides
AU2000267883A1 (en) * 2000-08-17 2002-02-25 Regen Therapeutics Plc Use of colostrinin, constituent peptides thereof, and analogs thereof for inducing cytokines
AU2000269178A1 (en) * 2000-08-17 2002-02-25 The University Of Texas System Use of colostrinin, constituent peptides thereof, and analogs thereof as oxidative stress regulators
WO2002013851A1 (en) * 2000-08-17 2002-02-21 The University Of Texas System Use of colostrinin, constituent peptides thereof, and analogs thereof to promote neural cell differentiation
GB0029777D0 (en) * 2000-12-06 2001-01-17 Regen Therapeutics Plc Peptides
HUP0200172A2 (hu) * 2002-01-15 2003-11-28 András Bertha Eljárás tumorellenes hatóanyag kinyerésére
US20050042300A1 (en) * 2002-10-22 2005-02-24 Istvan Boldogh Use of colostrinin, constituent peptides thereof, and analogs thereof as inhibitors of apoptosis and other cellular damage
ES2297398T3 (es) * 2003-03-11 2008-05-01 Regen Therapeutics Plc Purificacion de peptidos del calostro.
CN1313487C (zh) * 2003-06-10 2007-05-02 天津商学院 具有抗菌作用的免疫活性肽（Trpi）
WO2005041680A2 (en) * 2003-11-03 2005-05-12 Advanced Protein Systems A novel colostral fractionation process
EP1723951A1 (en) * 2005-04-21 2006-11-22 N.V. Nutricia Nutritional supplement with oligosaccharides for a category of HIV patients
US20070212367A1 (en) * 2006-03-13 2007-09-13 Keech Andrew M Novel immunologically active peptide fragments of a proline-rich polypeptide isolated from colostral mammalian fluids for treatment of viral and non-viral diseases or diseased conditions
GB2436328A (en) * 2006-03-22 2007-09-26 Regen Therapeutics Plc Peptide derived from colostrinin
US20110098216A1 (en) * 2009-10-22 2011-04-28 Regen Therapeutics Plc Therapeutic uses of colostrinin
ITMI20111460A1 (it) * 2011-07-29 2013-01-30 Bionest Ltd Composizioni per la terapia adiuvante dell'anoressia comprendenti anticorpi, fattori di crescita e citochine isolati dal colostro dei mammiferi
WO2013098331A1 (en) 2011-12-30 2013-07-04 Bionest Ltd. Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins c3a/c4a, and chemotactic factors
EP2797609B1 (en) 2011-12-30 2016-10-05 Innomed S.A. Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins c3a/c4a, immunoglobulins and chemotactic factors
ITMI20112433A1 (it) * 2011-12-30 2013-07-01 Bionest Ltd Composizioni per la terapia orale adiuvante dell'anoressia comprendenti anticorpi, antibatterici, fattori di crescita e citochine
GB201205856D0 (en) 2012-04-02 2012-05-16 Randall Jeremy A P Food supplement to support brain function
PL235821B1 (pl) * 2014-11-04 2020-11-02 Geo Poland Spolka Z Ograniczona Odpowiedzialnoscia Wysokoprolinowy kompleks peptydowy do zastosowania w profilaktyce i wspomaganiu leczenia zaburzeń i stanów wymagających podwyższania i/lub modulacji poziomu neurotropowego czynnika pochodzenia mózgowego jako oznaczonego w osoczu krwi biomarkera i zawierający go preparat
WO2016122567A1 (en) 2015-01-30 2016-08-04 Hewlett-Packard Development Company, L.P. M-ary cyclic coding
US12263192B2 (en) 2019-02-26 2025-04-01 Pantheryx, Inc. Compositions for management of disorders of the gastrointestinal tract

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE90569T1 (de) 1988-04-19 1993-07-15 Biotest Pharma Gmbh Praeparat mit antikoerperaktivitaet und breitem wirkungsspektrum, daraus bestehende oder diese enthaltende mittel und deren verwendung zur behandlung von bakteriell oder toxin-bedingten erkrankungen und zur bekaempfung von protozoen.
JPH05163160A (ja) * 1991-12-13 1993-06-29 Snow Brand Milk Prod Co Ltd 免疫低下に伴う感染症の予防及び治療用栄養剤
JP3174611B2 (ja) * 1992-02-28 2001-06-11 明治乳業株式会社 免疫賦活組成物
US5645834A (en) 1992-08-28 1997-07-08 Immuno-Dynamics, Inc. Method and product for treating failure of passive transfer and improving milk production in bovine species
GB9318611D0 (en) * 1993-09-08 1993-10-27 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
DE4337654C2 (de) 1993-11-04 1996-08-08 Biotest Pharma Gmbh Verwendung boviner Kolostralmilch von nicht mit Viren hyperimmunisierten Tieren als Leberschutzpräparat
JP4112021B2 (ja) * 1994-02-16 2008-07-02 明治乳業株式会社 乳酸菌を用いた免疫賦活剤
RU2062109C1 (ru) * 1994-11-28 1996-06-20 Товарищество с ограниченной ответственностью "Старк" Способ получения иммунного препарата
WO1997005884A1 (en) 1995-08-07 1997-02-20 New England Medical Center Hospitals, Inc. Infant formula and infant formula additives
DE19619990A1 (de) 1996-05-17 1997-11-20 Charlotte Adler Verfahren zur Herstellung von Kolostralmilchprodukten sowie deren Verwendung
PL185442B1 (pl) 1996-10-03 2003-05-30 Georgiades Biotech Ltd Środek farmaceutyczny o działaniu immunologicznym i psychotropowym, jego postać terapeutyczna oraz zastosowanie

Also Published As

Publication number Publication date
CN1238782A (zh) 1999-12-15
CN1131712C (zh) 2003-12-24
GB2333453B (en) 2001-05-30
AU4565197A (en) 1998-04-24
PL316416A1 (en) 1998-04-14
HUP9904368A3 (en) 2000-07-28
CA2266859C (en) 2012-05-08
WO1998014473A1 (en) 1998-04-09
CZ114999A3 (cs) 2000-06-14
KR20000048886A (ko) 2000-07-25
ZA978885B (en) 1999-07-26
CZ298215B6 (cs) 2007-07-25
JP2008174561A (ja) 2008-07-31
AR013612A1 (es) 2001-01-10
GB2333453A8 (en) 2000-11-27
CA2266859A1 (en) 1998-04-09
GB2333453A (en) 1999-07-28
RU2217152C2 (ru) 2003-11-27
KR20050046766A (ko) 2005-05-18
US20050152985A1 (en) 2005-07-14
PL185442B1 (pl) 2003-05-30
JP2001501929A (ja) 2001-02-13
EP0932623A1 (en) 1999-08-04
US6852700B1 (en) 2005-02-08
GB9908331D0 (en) 1999-06-09
TR199901022T2 (xx) 1999-07-21
KR100508764B1 (ko) 2005-08-17
HUP9904368A2 (hu) 2000-06-28
IL129211A (en) 2004-08-31
CN1535722A (zh) 2004-10-13
IL129211A0 (en) 2000-02-17

Similar Documents

Publication Publication Date Title
BR9712259A (pt) Colostrininin, uso do mesmo, processos de tratar distúrbios do sistema nervoso central e/ou do sistema imune, de preparar colostrinin de colostro de mamìferos e de produzir uma composição farmacêutica, composição farmacêutica, suplemento dietético, nanopeptìdeo, e, uso do mesmo.
NZ504026A (en) Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C
DK0454436T3 (da) Farmaceutiske præparater
CA2141436A1 (en) Treatment of Alzheimer's Disease and Modulation of Immune System with Delta-5-Androstenes
BG102708A (en) 4-aminopyrimidine derivatives, medicamentous preparations containing them, their application and method for their preparation
DE3777050D1 (de) Catecholderivate und vorbeugende sowie heilende praeparate fuer regressive stoerungen im zentralnervensystem.
ATE199167T1 (de) Nichtglykosyliertes fgf-4 und dieses enthaltende präparate
GB2367061A (en) Peptides
DE69719754D1 (de) Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung
EP0520200A3 (en) Imidazole compounds, their preparation and use
BR9607967A (pt) Uso de composições imunomodulares extraídas da bile para o tratamento das desordens do sistema imunológico fabricação do medicamento e emprego do mesmo
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
CA2131565A1 (en) Organopolysiloxanes Containing Hydrophilic Groups
CA2094275A1 (en) Methods and compositions for the treatment of cell proliferation disorders
ATE111357T1 (de) Synergetische immunostimulierende zusammensetzung und ihre verwendung.
IL93988A0 (en) Substituted 1,8-naphthyridines,their preparation and medicaments comprising them
ATE151774T1 (de) Cyclopentanperhydrophenanthren-17-beta-(3-furyl - 3-derivate und pharmazeutische präparate davon, zur behandlung von kardiovaskulär-erkrankungen
IL105498A0 (en) Pharmaceutical composition containing ribonucleotide polymerase
PL322284A1 (en) Derivatives of aminoteralin useful in treating diseases of cardiovascular system
DE3380923D1 (de) Pharmazeutische zusammensetzungen zur behandlung von stoerungen, bedingt durch humanendrogen.
IL158152A0 (en) Osteoprotegerin in milk
ES8104315A1 (es) Un procedimiento de obtencion de un extracto de las fraccio-nes polares de los helechos de la familia polypodiaceae.
MY103593A (en) Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation
ZA893310B (en) Novel strobilurine derivatives,their preparation and their use
ZA859695B (en) 2-(arylalkyloxymethyl)morpholine,preparation thereof and their application as drugs which are useful in the treatment of disorders of the central nervous system

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: DE ACORDO COM ART. 37, INDEFIRO O PRESENTE PEDIDO COM BASE NOS ART. 8O, 11 E 24 DA LPI VIGENTE.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.